Univercells
OverviewSuggest Edit
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.
Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Univercells positions itself as a global partner for developing biomanufacturing/biosimilar solution, going from the process design, to the selection of the best technologies (USP, DSP, filing technologies, etc), to the design of the clinical plan, the process development, the technology transfer, the facility construction or the training of the staff.
| Type | Private | |
| Founded | 2013 | |
| HQ | Charleroi, BE | Map |
| Website | univercells.com |
Recent NewsAll News
Latest Updates
| Employees (est.) (Jan 2021) | 133 | (+8%) |
| Cybersecurity rating | B | More |
Key People/Management at Univercells
Hugues Bultot
Jose Castillo
Mathias Garny
Vincent Vanderborght
Christian Borgniet
Cécile Jacoby
Univercells Office Locations
Univercells Financials and Metrics
Summary Metrics
Founding Date | 2013 |
Univercells total Funding | $37.7 m |
Univercells latest funding size | $18.80 m |
Time since last funding | 3 years ago |
Univercells investors | Takeda Ventures, Bill & Melinda Gates Foundation, Global Health Investment Fund |
Univercells Cybersecurity Score
Univercells Online and Social Media Presence
387 Twitter followers
Univercells has 387 Twitter Followers. The number of followers has increased 1.4% month over month and increased 2.7% quarter over quarter
Univercells's Trends
Twitter Engagement Stats for @biologicsforall
494
Tweets
280
Following
387
Followers
2
Tweets last 30 days
2.5
Avg. likes per Tweet
100%
Tweets with engagement
Univercells News and Updates
Univercells nets $3.56 mln Series A
Univercells Blogs
Univercells Holding raises €70 million in Series C Financing
Univercells Technologies introduces the NevoLine™ Upstream Platform
Univercells Technologies is building capacity for gene therapy production
Exyte & Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic
Launch of Univercells Technologies for intensified, automated technologies
ReiThera, Leukocare and Univercells announce fast-track development of a COVID-19 vaccine
Univercells Frequently Asked Questions
When was Univercells founded?
Univercells was founded in 2013.
Who are Univercells key executives?
Univercells's key executives are Hugues Bultot, Jose Castillo and Mathias Garny.
How many employees does Univercells have?
Univercells has 133 employees.
Who are Univercells competitors?
Competitors of Univercells include SmartZyme, Servier and NovaBay Pharmaceuticals.
Where is Univercells headquarters?
Univercells headquarters is located at Rue Auguste Piccard 48, Charleroi.
Where are Univercells offices?
Univercells has offices in Charleroi, Nivelles and Woluwe-Saint-Pierre.
How many offices does Univercells have?
Univercells has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies